AUL
ARVN icon

AlphaGrep UK Ltd’s Arvinas ARVN Stock Holding History

AlphaGrep UK Ltd’s Portfolio ARVN Stock Details ARVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-16,999
Closed -$202K – 780
2025
Q4 		$202K Buy
+16,999
New +$186K 0.07% 626

Other funds holding ARVN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

AlphaGrep UK Ltd's ARVN Position: Q1 2026 in Review

AlphaGrep UK Ltd sold out of Arvinas (ARVN) in Q1 2026, closing a stake of 16,999 shares — an estimated $202K sold.

AlphaGrep UK Ltd first reported a position in ARVN in Q4 2025 and held it in 1 quarter. The position peaked at $202K in Q4 2025. 206 funds tracked by Wall St. Rank hold ARVN as of Q1 2026.

  • AlphaGrep UK Ltd reported no remaining Arvinas position as of Q1 2026 after selling out during the quarter.
  • AlphaGrep UK Ltd sold 16,999 Arvinas shares in Q1 2026, an estimated $202K.
  • AlphaGrep UK Ltd first reported a position in Arvinas in Q4 2025 and held it in 1 quarter.
  • AlphaGrep UK Ltd's Arvinas position peaked at $202K in Q4 2025.
  • 206 funds tracked by Wall St. Rank held Arvinas as of Q1 2026.

Based on AlphaGrep UK Ltd's 13F filing for Q1 2026, filed 13 Aug 2026.